Market Overview

My goal is to be on stage with my computer and let you
see my screen and make sure you know what buttons to
press, where you’re getting in & out, how to calculate
risk, your targets — all of those things.
It’s real-life trading. Make sure you sign up!
- Jerremy Newsome

DexCom Q1 Earnings Preview


DexCom (NASDAQ: DXCM) releases its next round of earnings this Wednesday, May 1. Get the latest predictions in Benzinga's essential guide to the company's first-quarter earnings report.

Earnings and Revenue

Wall Street analysts see DexCom reporting a quarterly loss of 16 cents per share on sales of $246.39 million.

In the same quarter last year, DexCom reported an EPS loss of 32 cents on revenue of $184.4 million. Sales would be up 33.62 percent from the same quarter last year. Here's how the company's reported EPS has compared to analyst estimates in the past:


Quarter Q4 2018 Q3 2018 Q2 2018 Q1 2018 Q4 2017
EPS Estimate 0.17 -0.1 -0.18 -0.33 0.03
EPS Actual 0.54 0.17 -0.1 -0.32 0.1

Stock Performance

Over the last 52-week period, shares are up 65.44 percent. Given that these returns are generally positive, long-term shareholders can relax going into this earnings release. Long-term shareholders are already enjoying 12-month gains prior to the announcement.

Analyst estimates have adjusted higher for EPS and revenues over the past 90 days. The most common rating from analysts on DexCom stock is a Neutral. The strength of this rating has maintained conviction over the past three months.

Conference Call

DexCom's conference call is scheduled to begin at 4:30 p.m. ET and can be accessed here:

Posted-In: Earnings News


Related Articles (DXCM)

View Comments and Join the Discussion!

Hologic's Q2 Earnings Preview

Oppenehimer Says Zendesk's Moderating Upside Prevents A Bullish Stance